JP2024516681A5 - - Google Patents
Info
- Publication number
- JP2024516681A5 JP2024516681A5 JP2023566811A JP2023566811A JP2024516681A5 JP 2024516681 A5 JP2024516681 A5 JP 2024516681A5 JP 2023566811 A JP2023566811 A JP 2023566811A JP 2023566811 A JP2023566811 A JP 2023566811A JP 2024516681 A5 JP2024516681 A5 JP 2024516681A5
- Authority
- JP
- Japan
- Prior art keywords
- biomarker
- amount
- subject
- risk
- assessment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21171488 | 2021-04-30 | ||
| EP21171488.6 | 2021-04-30 | ||
| PCT/EP2022/061583 WO2022229440A2 (en) | 2021-04-30 | 2022-04-29 | Sflt1 marker panels for early detection of sepsis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516681A JP2024516681A (ja) | 2024-04-16 |
| JP2024516681A5 true JP2024516681A5 (https=) | 2025-04-24 |
Family
ID=75746430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023566811A Pending JP2024516681A (ja) | 2021-04-30 | 2022-04-29 | 敗血症の早期検出のためのｓＦｌｔ１マーカーパネル |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240230675A1 (https=) |
| EP (1) | EP4330687A2 (https=) |
| JP (1) | JP2024516681A (https=) |
| CN (1) | CN117255947A (https=) |
| WO (1) | WO2022229440A2 (https=) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2476597C (en) | 2002-02-28 | 2011-05-17 | Metanomics Gmbh & Co. Kgaa | Mass spectrometry method for analysing mixtures of substances |
| US20090197794A1 (en) * | 2005-07-13 | 2009-08-06 | Aird William C | Methods of Diagnosing and Treating an Inflammatory Response |
| AU2006299417A1 (en) * | 2005-10-03 | 2007-04-12 | Biosite Incorporated | Methods and compositions for diagnosis and/or prognosis in Systemic Inflammatory Response Syndromes |
| CN103123359B (zh) | 2007-08-03 | 2015-07-29 | B.R.A.H.M.S有限公司 | 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用 |
| JP5722587B2 (ja) | 2009-10-13 | 2015-05-20 | ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 急性脳卒中または一過性脳虚血発作を有する患者における細菌感染の診断のためのプロカルシトニン及び抗生物質治療のガイダンス |
| RU2016112915A (ru) | 2013-09-05 | 2017-10-09 | Эф-Ай-Оу Корпорейшн | Биомаркеры для раннего выявления критической или угрожающей жизни ответной реакции на заболевание и/или ответной реакции на лечение |
| GB201402293D0 (en) * | 2014-02-11 | 2014-03-26 | Secr Defence | Biomarker signatures for the prediction of onset of sepsis |
| JP6859334B2 (ja) * | 2015-10-08 | 2021-04-14 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 手術前に測定した際にａｋｉのリスクを予測するためのｉｇｆｂｐ７ |
| US20190178897A1 (en) * | 2016-08-09 | 2019-06-13 | B.R.A.H.M.S Gmbh | Histones and/or proadm as markers indicating organ dysfunction |
-
2022
- 2022-04-29 WO PCT/EP2022/061583 patent/WO2022229440A2/en not_active Ceased
- 2022-04-29 JP JP2023566811A patent/JP2024516681A/ja active Pending
- 2022-04-29 US US18/558,144 patent/US20240230675A1/en active Pending
- 2022-04-29 CN CN202280030900.3A patent/CN117255947A/zh active Pending
- 2022-04-29 EP EP22726667.3A patent/EP4330687A2/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bauer et al. | Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: machine learning on proteomics from the DETECT cohort | |
| Kamath et al. | A model to predict survival in patients with end‐stage liver disease | |
| Chandarana et al. | Visceral adipose tissue in patients with COVID-19: risk stratification for severity: H. Chandarana et al. | |
| Zink et al. | Segmental bioelectrical impedance spectroscopy to monitor fluid status in heart failure | |
| JP5832425B2 (ja) | 腎臓病診断用マーカー及びその利用 | |
| CN112805789A (zh) | 诊断肝脂肪变性的方法 | |
| US20130210667A1 (en) | Biomarkers for Predicting Kidney and Glomerular Pathologies | |
| Kavsak et al. | High-sensitivity cardiac troponin risk cutoffs for acute cardiac outcomes at emergency department presentation | |
| Wu et al. | Prediction of the sarcopenia in peritoneal dialysis using simple clinical information: A machine learning‐based model | |
| Makaryus et al. | Falsely elevated cardiac troponin I levels | |
| Tan et al. | Serum creatinine/cystatin C ratio as a case-finding tool for low handgrip strength in Chinese middle-aged and older adults | |
| JP2024516678A5 (https=) | ||
| JP2024516680A5 (https=) | ||
| JP2024516681A5 (https=) | ||
| JP2024516677A5 (https=) | ||
| Fang et al. | Usefulness of the serum creatinine/cystatin C ratio as a blood biomarker for sarcopenia components among age groups in community‐dwelling older people: the SONIC study | |
| JP6401297B2 (ja) | インスリン分泌能分析装置、当該装置を備えるインスリン分泌能分析システム及びインスリン分泌能分析方法 | |
| JP2024516001A5 (https=) | ||
| JP6727660B2 (ja) | 糖尿病性腎症の判定マーカー | |
| JP2024537774A5 (https=) | ||
| WO2024154832A1 (ja) | 全身性強皮症の検出方法 | |
| CN115586342B (zh) | 血清可溶性st2在制备预测主动脉夹层患者预后产品中的应用及相关预测装置 | |
| JP2024515086A5 (https=) | ||
| JP2024516679A5 (https=) | ||
| JP2024516665A5 (https=) |